Unambiguous detection and quantification of 3-(2-deoxy-β-D-erythro-pentofuranosyl)-4,6,7,8-tetrahydro-6-hydroxy-pyrimido[1,2-a]purin-10(3H)-one (6-HO-PdG) from the reaction of acrolein with calf thymus DNA

TOXI 119

Guillermo R. Alas, Willie.alas@Vanderbilt.Edu, Ivan D. Kozekov, ivan.kozekov@vanderbilt.edu, Constance M. Harris, constance.m.harris@vanderbilt.edu, Thomas M Harris, thomas.h.harris@vanderbilt.edu, and Carmelo J. Rizzo, c.j.rizzo@vanderbilt.edu. Department of Chemistry, Center in Molecular Toxicology and the Vanderbilt-Ingram Cancer Center, Vanderbilt University, PO Box 1822B, Nashville, TN 37235

Acrolein reacts with deoxyguanosine to form both the 8-hydroxy- (1) and 6-hydroxy-1,N2-propano (2) adducts.  However, only 1 has been unambiguously identified and quantified from acrolein treated DNA and intact cells.  We have developed a sensitive and selective UPLC/MS/MS method for the identification and quantification of both adducts.  Calf thymus DNA was incubated with acrolein over a range of concentrations for 24 h at 37o C, then subjected to enzymatic digestion.  Adduct 2 co-eluted with dA, which obscured its identification. However, adduct 2 was clearly visible after the hydolysate was treated with adenosine deaminase.  The acrolein adducts were quantified by the stable isotope dilution method, and the level of 2 was determined to be ~25 % that of 1.